HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Mr. Robert Eno est le Chief Executive Officer de Heartbeam Inc, il a rejoint l'entreprise depuis 2023.
Quelle est la performance du prix de l'action BEAT ?
Le prix actuel de BEAT est de $1.21, il a augmenté de 2.54% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Heartbeam Inc ?
Heartbeam Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Heartbeam Inc ?
La capitalisation boursière actuelle de Heartbeam Inc est de $41.6M
Est-ce que Heartbeam Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 6 analystes ont établi des notations d'analystes pour Heartbeam Inc, y compris 2 achat fort, 4 achat, 2 maintien, 0 vente et 2 vente forte